Gene expression in the LNCaP human prostate cancer progression model: Progression associated expression in vitro corresponds to expression changes associated with prostate cancer progression in vivo

This publication has 63 references indexed in Scilit:

• EXPRESSION PROFILES OF ANDROGEN INDEPENDENT BONE METASTATIC PROSTATE CANCER CELLS INDICATE UP-REGULATION OF THE PUTATIVE SERINE-THREONINE KINASE GS3955
  Journal of Urology, 2004
• Humoral Immune Response to -Methylacyl-CoA Racemase and Prostate Cancer
  JNCI Journal of the National Cancer Institute, 2004
• PGP9.5 mRNA could contribute to the molecular-based diagnosis of medullary thyroid carcinoma
  European Journal Of Cancer, 2004
• Lineage relationship between LNCaP and LNCaP‐derived prostate cancer cell lines
  The Prostate, 2004
• The UCH-L1 Gene Encodes Two Opposing Enzymatic Activities that Affect α-Synuclein Degradation and Parkinson's Disease Susceptibility
  Cell, 2002
• The role of inhibins and activins in prostate cancer pathogenesis.
  Endocrine-Related Cancer, 2000
• LNCaP progression model of human prostate cancer: Androgen-independence and osseous metastasis
  The Prostate, 2000
• Mutations in the gene encoding peroxisomal α-methylacyl-CoA racemase cause adult-onset sensory motor neuropathy
  Nature Genetics, 2000
• Substrate Binding and Catalysis by Ubiquitin C-Terminal Hydrolases: Identification of Two Active Site Residues
  Biochemistry, 1996
• Molecular cloning of cDNA coding for human PGP 9.5 protein
  FEBS Letters, 1987